-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Targeted therapy and immunotherapy for tumors are beginning to change the way doctors think about cancer treatment, which is based on specific genetic changes and abnormal molecular structural characteristics of a tumor, rather than just deciding how to treat a tumor based on a specific tissue or part or site where the tumor grows in the body
What is tumor agnostic treatment?
A tumor-independent treatment is a drug treatment that can be used to treat any type of cancer, regardless of where the tumor originated in the body or from which tissue type
What treatments have been approved so far for the treatment of an unrelated tumor type?
Pembrolizumab was the earliest approved drug
In 2020, the FDA approved pembrolizumab for the treatment of non-resectable or metastatic solid tumors of adults and children with high tumor mutational burden (TMB-H) and other
Since 2018, the FDA has also approved two targeted drugs: larotrectinib and enterinib for the treatment of adult and pediatric solid tumors
What is a basket trial?
Doctors and scientists are always looking for better ways to treat cancer patients
What does treatment regardless of tumor type mean to patients?
Treatments that are independent of tumor type represent a new way of how to treat cancer, which is completely different from